212 related articles for article (PubMed ID: 26704781)
1. Malignant-functioning neuroendocrine tumors of the pancreas: A survival analysis.
Keutgen XM; Nilubol N; Kebebew E
Surgery; 2016 May; 159(5):1382-9. PubMed ID: 26704781
[TBL] [Abstract][Full Text] [Related]
2. Survival impact of malignant pancreatic neuroendocrine and islet cell neoplasm phenotypes.
Roland CL; Bian A; Mansour JC; Yopp AC; Balch GC; Sharma R; Xie XJ; Schwarz RE
J Surg Oncol; 2012 May; 105(6):595-600. PubMed ID: 22006521
[TBL] [Abstract][Full Text] [Related]
3. Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors?
Fernández-Cruz L; Blanco L; Cosa R; Rendón H
World J Surg; 2008 May; 32(5):904-17. PubMed ID: 18264824
[TBL] [Abstract][Full Text] [Related]
4. [Hormone inactive neuroendocrine tumors of the pancreas].
Schwab M; Knoll MR; Jentschura D; Hagmüller E
Chirurg; 1997 Jul; 68(7):705-9. PubMed ID: 9340236
[TBL] [Abstract][Full Text] [Related]
5. Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas.
Matthews BD; Heniford BT; Reardon PR; Brunicardi FC; Greene FL
Am Surg; 2000 Dec; 66(12):1116-22; discussion 1122-3. PubMed ID: 11149582
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis.
Poultsides GA; Huang LC; Chen Y; Visser BC; Pai RK; Jeffrey RB; Park WG; Chen AM; Kunz PL; Fisher GA; Norton JA
Ann Surg Oncol; 2012 Jul; 19(7):2295-303. PubMed ID: 22396008
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic neuroendocrine tumours.
Ruiz-Tovar J; Priego P; Martínez-Molina E; Morales V; Sanjuanbenito A; Lobo E
Clin Transl Oncol; 2008 Aug; 10(8):493-7. PubMed ID: 18667380
[TBL] [Abstract][Full Text] [Related]
8. Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients.
Phan GQ; Yeo CJ; Hruban RH; Lillemoe KD; Pitt HA; Cameron JL
J Gastrointest Surg; 1998; 2(5):472-82. PubMed ID: 9843608
[TBL] [Abstract][Full Text] [Related]
9. [Operative management and long-term survival in patients with neuroendocrine tumors of the pancreas--experience with 144 patients].
Fendrich V; Habbe N; Celik I; Langer P; Zielke A; Bartsch DK; Rothmund M
Dtsch Med Wochenschr; 2007 Feb; 132(5):195-200. PubMed ID: 17252361
[TBL] [Abstract][Full Text] [Related]
10. Population-based study of islet cell carcinoma.
Yao JC; Eisner MP; Leary C; Dagohoy C; Phan A; Rashid A; Hassan M; Evans DB
Ann Surg Oncol; 2007 Dec; 14(12):3492-500. PubMed ID: 17896148
[TBL] [Abstract][Full Text] [Related]
11. A personal experience with pancreatic and duodenal neuroendocrine tumors.
Jordan PH
J Am Coll Surg; 1999 Nov; 189(5):470-82. PubMed ID: 10549736
[TBL] [Abstract][Full Text] [Related]
12. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
13. Cytoreduction results in high perioperative mortality and decreased survival in patients undergoing pancreatectomy for neuroendocrine tumors of the pancreas.
Bloomston M; Muscarella P; Shah MH; Frankel WL; Al-Saif O; Martin EW; Ellison EC
J Gastrointest Surg; 2006 Dec; 10(10):1361-70. PubMed ID: 17175455
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine tumors of the pancreas.
Varshney S; Johnson CD
Indian J Gastroenterol; 2000; 19(4):181-3. PubMed ID: 11059186
[TBL] [Abstract][Full Text] [Related]
15. Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size.
Kuo EJ; Salem RR
Ann Surg Oncol; 2013 Sep; 20(9):2815-21. PubMed ID: 23771245
[TBL] [Abstract][Full Text] [Related]
16. Determinants of surgical resection for pancreatic neuroendocrine tumors.
Doi R
J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):610-7. PubMed ID: 25773163
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in resected pancreatic neuroendocrine tumours: Experience in 95 patients.
Sánchez-Bueno F; Rodríguez González JM; Torres Salmerón G; Bernabé Peñalver A; Balsalobre Salmeron M; de la Peña Moral J; Fuster Quiñonero M; Parrilla Paricio P
Cir Esp; 2016 Oct; 94(8):473-80. PubMed ID: 27450270
[TBL] [Abstract][Full Text] [Related]
18. Resection of pancreatic neuroendocrine tumors: results of 70 cases.
Kazanjian KK; Reber HA; Hines OJ
Arch Surg; 2006 Aug; 141(8):765-9; discussion 769-70. PubMed ID: 16924083
[TBL] [Abstract][Full Text] [Related]
19. Extended surgery for advanced pancreatic endocrine tumours.
Kleine M; Schrem H; Vondran FW; Krech T; Klempnauer J; Bektas H
Br J Surg; 2012 Jan; 99(1):88-94. PubMed ID: 22135173
[TBL] [Abstract][Full Text] [Related]
20. Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors.
Tierney JF; Chivukula SV; Wang X; Pappas SG; Schadde E; Hertl M; Poirier J; Keutgen XM
Surgery; 2019 Mar; 165(3):644-651. PubMed ID: 30366604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
